ABIONYX PHARMA EUR0.05 financial statements, including revenue, expenses, profit, and loss
The total revenue of 0RAG for the last semiannual is 2.47 M EUR, and it's 16.17% higher compared to the previous semiannual. The net income of H2 23 is -1.25 M EUR.